Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results

Go back to Cardlytics Announces Fourth Quarter and Full Year 2025 Financial Results

Cardlytics (CDLX) Tops Q4 EPS by 28c, Beats on Revenue

March 4, 2026 4:04 PM EST

Cardlytics (NASDAQ: CDLX) reported Q4 EPS of $0.00, $0.28 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $56.1 million versus the consensus estimate of $55.17 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

... More